The store will not work correctly when cookies are disabled.
US8796295, Table 2: Compound: 9
ID: ALA3694789
PubChem CID: 86654696
Max Phase: Preclinical
Molecular Formula: C16H14FN5OS
Molecular Weight: 343.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1csc(NC(=O)c2cc(F)cc(N(C)c3cncnc3)c2)n1
Standard InChI: InChI=1S/C16H14FN5OS/c1-10-8-24-16(20-10)21-15(23)11-3-12(17)5-13(4-11)22(2)14-6-18-9-19-7-14/h3-9H,1-2H3,(H,20,21,23)
Standard InChI Key: JHFMVNJTXHIDIX-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
3.6375 -0.9049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8915 -3.7585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8864 -5.2585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9235 -5.8621 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.5847 -6.0040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2883 -5.2495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2935 -3.7495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0156 -5.9927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0218 -7.1927 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3117 -5.2360 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6155 -5.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9648 -5.3535 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.9723 -6.4648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.1653 -6.3352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2268 -7.7664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7585 -7.4596 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
2 9 1 0
9 10 2 0
10 11 1 0
11 12 1 0
11 13 2 0
13 14 1 0
14 15 2 0
15 9 1 0
14 16 1 0
16 17 2 0
16 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 1 0
21 23 2 0
23 24 1 0
24 19 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 343.39 | Molecular Weight (Monoisotopic): 343.0903 | AlogP: 3.40 | #Rotatable Bonds: 4 |
Polar Surface Area: 71.01 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.87 | CX Basic pKa: 1.83 | CX LogP: 2.42 | CX LogD: 2.42 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.79 | Np Likeness Score: -2.45 |
References
1. (2014) Substituted benzamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same, |